Skip to main content
main-content

01.12.2017 | Case report | Ausgabe 1/2017 Open Access

Journal of Medical Case Reports 1/2017

Two synchronous malignant tumors of the pancreas: a case report

Zeitschrift:
Journal of Medical Case Reports > Ausgabe 1/2017
Autoren:
W. S. L. De Silva, A. A. Pathirana, I. Prematilleke, S. A. P. D. Rajapakse, P. S. H. Hettiarachchi, D. S. Manawasinghe, B. K. Dassanayake
Abbreviations
AJCC
American Joint Committee on Cancer
ALP
Alkaline phosphatase
BMI
Body mass index
CBD
Common bile duct
CEA
Carcinoembryonic antigen
CECT
Contrast-enhanced computed tomography
CK
Cytokeratin
CT
Computed tomography
EMA
Epithelial membrane antigen
ERCP
Endoscopic retrograde cholangiopancreatography
EUS-FNAB
Endoscopic ultrasound-guided fine needle aspiration biopsy
IPMN
Intraductal papillary mucinous neoplasm
MDCT
Multidetector computed tomography
MDT
Multidisciplinary team
MET
Metabolic equivalent of task
MRI
Magnetic resonance imaging
NET
Neuroendocrine tumor
SEMS
Self-expandable metal stent

Background

The finding of synchronous primary tumors involving one organ is rare. Only a few cases of multiple solid primary pancreatic tumors have been reported in the literature [1, 2]. Most such multiple tumors were found in previously diseased pancreases with chronic pancreatitis [1]. We report our management experience of a preoperatively detected ampullary adenocarcinoma and a mucinous pancreatic adenocarcinoma involving the tail.

Case presentation

A 65-year-old previously healthy Sri Lankan woman was referred for the management of progressive painless obstructive jaundice of 1-month duration. She had two episodes of cholangitis which had been managed with antibiotics administered intravenously. There was loss of appetite and loss of weight (12 kg/month). Her premorbid metabolic equivalent of task (MET) score was >6, but was only 3 when she was referred. She was icteric and had mild dependent edema. Her body mass index (BMI) was 17. There were no palpable abdominal masses.
She had biochemical evidence of obstructive jaundice: total bilirubin 3.4 mg/dL, direct bilirubin 3.0 mg/dL, and alkaline phosphatase (ALP) 624 IU/dL. Contrast-enhanced computed tomography (CECT) only identified a 26×37 mm tumor in the pancreatic tail with a mildly dilated common bile duct (CBD) without an apparent cause for it. Since she was unfit for major surgery an endoscopic retrograde cholangiopancreatography (ERCP) was performed, which demonstrated a stricture with smooth tapering at the distal end of her CBD. The ampulla was prominent but there was no evidence of a mass lesion from which to take a biopsy. Brush cytology from the stricture was negative for malignant cells. A 6 cm self-expandable metal stent (SEMS) was inserted. Following the endoscopic intervention, her icterus disappeared and her liver profile improved. In order to find out the cause for the distal CBD stricture, a second computed tomography (CT) scan combined with multimodal magnetic resonance imaging (MRI) of her abdomen was performed. This combined CT/MRI of her abdomen detected a second tumor in her pancreas; it was a mass with ill-defined margins of 17×19 mm, which invaded adjacent pancreatic tissue just inferior to the distal end of her CBD. Her superior mesenteric artery or vein was not involved (Fig. 1).
Her American Joint Committee on Cancer (AJCC) stage was 2A for both tumors (ampullary tumor T3, N0, M0 and the tumor of the tail T2, N0, M0). The decision to offer total pancreaticoduodenectomy was taken in a multidisciplinary team (MDT) meeting because of the anatomical location of the two tumors. She was referred to a nutritionist and was optimized with supplementary parenteral nutrition for 3 weeks. She was also vaccinated to prepare her for a possible splenectomy. Her performance status improved within 3 weeks and a total pancreaticoduodenectomy and splenectomy were performed. Her postoperative period was complicated by a lower respiratory tract infection, superficial surgical site infection, and poor glycemic control. She was managed in a surgical ward with the support of endocrinology, microbiology, and nutrition teams and was discharged on the tenth postoperative day. She was discharged on insulin and oral penicillin for prophylaxis. She lost 7 kg of weight postoperatively but her weight stabilized after the introduction of a special dietary regimen which included six to eight small frequent meals with energy-dense snacks and limitation of food rich in carbohydrates and fat.
A macroscopic examination of the resected specimen revealed two distinct tumors in her pancreas. One was an ampullary tumor measuring 30×30×28 mm. The second tumor was found at the tail and measured 50×42×40 mm. The distance between the two tumors was 40 mm.
An histologic examination of the ampullary tumor (Fig. 2a) showed a moderately differentiated ampullary adenocarcinoma of pancreaticobiliary type. This tumor had invaded the muscularis propria of her duodenum and the pancreatic parenchyma. Her CBD was not infiltrated by the tumor. Vascular and perineural invasion were not seen. The tumor at the pancreatic tail (Fig. 2b) showed a moderately differentiated non-cystic mucinous (colloid) adenocarcinoma. Perineural invasion was seen, but vascular invasion was not detected. A few areas of chronic pancreatitis were noted in the rest of the pancreas but largely the morphology of the pancreas was normal. Immunohistochemistry findings are shown in Table 1.
Table 1
Immunohistochemistry of the two tumors (Dako®)
Stain
Cytokeratin 7
Cytokeratin 20
Carcinoembryonic antigen
Epithelial membrane antigen
Tumor 1 (ampulla)
Strongly positive
Negative
Focally positive
Strongly positive
Tumor 2 (tail of pancreas – colloid carcinoma)
Strongly positive
Focally positive
Strongly positive
Strongly positive
She had good quality life after surgery reaching her premorbid MET score of 6 and had a stable weight. However, her serum albumin level was persistently low (median 26 mg/dL). She died of severe pneumonia 8 months after surgery.

Discussion

Synchronous primary tumors of the pancreas are rare and most of them were found in previously diseased pancreases with chronic pancreatitis or associated with premalignant lesions like intraductal papillary mucinous neoplasm (IPMN). An association of IPMN with multifocal ductal adenocarcinoma is well established. Yamaguchi et al. reported that 20% of cases in a series of 765 patients who underwent surgery for IPMN had pancreatic ductal adenocarcinoma either derived from IPMN or concomitant with IPMN [3]. Solid pseudopapillary neoplasm too is synchronously found with IPMN [4]. However, multifocal involvement in a previously healthy pancreas has not been reported to the best of our knowledge.
A case of two separate malignant tumors of the pancreas was reported by Goong et al. where a tumor in the head and another in the tail of the pancreas were identified preoperatively [2]. Both lesions were finally recognized as ductal adenocarcinomas by endoscopic ultrasound-guided fine needle aspiration biopsy (EUS-FNAB), but the histologic separation of the two tumors could not be proven in this case as the patient had refused surgery. Sastry et al. reported a case of three synchronous tumors of the pancreas; an ampullary carcinoma with two other tumors was found incidentally in the head and in the uncinate process, during histologic preparation [1]. In this case, the ampullary tumor was of a poorly differentiated adenosquamous variety whereas the tumor in the uncinate process was a moderately differentiated adenocarcinoma and the tumor in the head of the pancreas was a benign neuroendocrine tumor (NET). Evidence of background chronic pancreatitis was well recognized. On immunohistochemical examination, pancreatic tumors do not have very specific markers. Those we had access to fitted with the morphological diagnosis; ampullary adenocarcinomas of pancreaticobiliary type are usually cytokeratin (CK) 7+/CK20– [5] and non-cystic mucinous (colloid) carcinoma CK7+/CK20+ [6]. Carcinoembryonic antigen (CEA) and epithelial membrane antigen (EMA) positivity is reported in both tumors [7].
For accurate diagnosis and staging of pancreatic neoplasms, integrated imaging is recommended. If multidetector computed tomography (MDCT) is the preferred imaging modality, multimodal MRI is recommended for integration in imaging for pancreatic tumors [8]. The cause for obstructive jaundice was not detected in the initial imaging in this case due to the low resolution of the CECT. After ERCP confirmed the presence of a lower CBD stricture, CECT combined with multimodal MRI (integrated imaging) was able to detect the tumor at the head of her pancreas in addition to the previously detected tumor at the tail.

Conclusions

The possibility of multiple primary malignant solid tumors of different histological types has to be considered when managing multiple tumors in the pancreas. This case demonstrates the importance of utilizing optimum imaging facilities for accurate preoperative diagnosis in order to plan the most appropriate treatment option.

Acknowledgements

The authors wish to acknowledge the support staff of Asiri Surgical hospital and the Department of Pathology, Faculty of Medical Sciences, University of Sri Jayewardenepura for support in compiling the figures in the article.

Funding

No funding was received for this study.

Availability of data and materials

Not applicable.

Authors’ contributions

WSLD followed up the patient, compiled the patient details, and wrote the manuscript. AAP, DSM, BKD, and WSLD were involved in the surgery and the decision making in patient management. PSHH reported on imaging and provided the CT/MRI figures. IP and SAPDR reported on histology and immunohistochemistry and provided images for pathology figures. AAP and IP revised and restructured the manuscript. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Ethics approval and consent to participate

Ethical approval for the publication of this case report was obtained from the ethics review committee, Faculty of Medical Sciences, University of Sri Jayewardenepura, Gangodawila, Nugegoda, Sri Lanka.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

e.Med Allgemeinmedizin

Kombi-Abonnement

Mit e.Med Allgemeinmedizin erhalten Sie Zugang zu allen CME-Fortbildungen und Premium-Inhalten der allgemeinmedizinischen Zeitschriften, inklusive einer gedruckten Allgemeinmedizin-Zeitschrift Ihrer Wahl.​​​​​​​​​​​​​​

Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2017

Journal of Medical Case Reports 1/2017 Zur Ausgabe